Patients are relying on Lyft, Uber to travel far distances to medical care

Catal­ent, the con­tract man­u­fac­tur­er in the process of over­haul­ing its op­er­a­tions, is man­u­fac­tur­ing Sarep­ta Ther­a­peu­tics’ new­ly ap­proved gene ther­a­py for Duchenne mus­cu­lar dy­s­tro­phy at one

New American guidelines for chronic coronary disease (CCD) modify management considerations for a heterogeneous group that includes people with or without angina, a history of